Vivos (RDGL) Current Leases (2010 - 2025)

Vivos (RDGL) reported Current Leases of $25420.0 for Q4 2025, down 35.61% sequentially from $39481.0 in Q4 2014.

Vivos (RDGL) Current Leases (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 6 years of Current Leases data on file, last reported at $25420.0 in Q4 2025.

For the quarter ending Q4 2025, Current Leases changed N/A year-over-year to $25420.0; the trailing twelve-month figure through Dec 2025 stood at $25420.0 (changed N/A YoY), and the FY2025 full-year result was $25420.0, changed N/A from the prior year.
Current Leases declined to $25420.0 in Q4 2025, from $39481.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $25420.0 in Q4 2025 to a low of $25420.0 in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	-
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	24.30 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	20.50 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	-
10	Vivos	27.16 Mn	25.60 Mn	-3,105.00	25,420.00

Historic Data

Download Data

Date	Value
Dec 31, 2025	25,420.00
Dec 31, 2014	39,481.00
Sep 30, 2014	109,421.00
Jun 30, 2014	177,645.00
Mar 31, 2014	244,648.00
Dec 31, 2013	309,145.00
Sep 30, 2013	264,607.00
Jun 30, 2013	175,287.00
Mar 31, 2013	319,505.00
Dec 31, 2012	346,270.00
Sep 30, 2012	366,768.00
Jun 30, 2012	815,708.00
Mar 31, 2012	925,033.00
Dec 31, 2011	427,813.00
Sep 30, 2011	425,000.00
Jun 30, 2011	417,000.00
Dec 31, 2010	405,338.00